SC 13D
SC 13D
- Company
- Adicet Bio, Inc.
- Filed
- February 9, 2018
- Accession Number
- 0001193125-18-038183
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →